United States House Energy Subcommittee on Health

PAVmed and Lucid Chairman and Chief Executive Officer, Dr. Lishan Aklog, Testifies at U.S. House of Representatives Energy and Commerce Committee, Hearing on Life-Saving Innovations and Medicare Coverage

Retrieved on: 
Wednesday, July 19, 2023
CMS, Medical device, Centers for Medicare & Medicaid Services, Event, Health equity, Cancer, National Cancer Institute, Esophageal cancer, Translation, United States House Energy Subcommittee on Health, Preprint, Committee, Emerging technologies, Medicare, Administration, Lucid, Congress, M.D, Hearing, Executive Committee, Reading, AdvaMed, JCP Executive Committee, House, Interstate Commerce Committee, Pharmaceutical industry, Health

NEW YORK, July 19, 2023 /PRNewswire/ -- PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid Diagnostics" or "Lucid"), a commercial-stage cancer prevention diagnostics company, announced that PAVmed and Lucid's Chairman and Chief Executive Officer, Lishan Aklog, M.D, testified yesterday at the U.S. House of Representatives Energy and Commerce Committee, Subcommittee on Health, hearing entitled "Innovation Saves Lives: Evaluating Medicare Coverage Pathways for Innovative Drugs, Medical Devices, and Technology".

Key Points: 
  • 1691 ) and the proposed Center for Medicare and Medicaid Services ("CMS") Transitional Coverage for Emerging Technologies ( TCET ) pathway.
  • During questioning, he vigorously argued that there is no justification for TCET to exclude molecular diagnostic testing which lies "…at the leading edge of innovation."
  • EsoGuard successfully detected a very late stage esophageal precancer, for which he successfully underwent curative ablation treatment to prevent progression to cancer.
  • A copy of Dr. Aklog' s prepared written testimony and link to a video of the full hearing can be found on the PAVmed and Lucid websites in the Investor Relations section, under "Events".

MARCH OF DIMES TESTIFIES BEFORE CONGRESS ON THE NEED TO PRIORITIZE MOM & BABY HEALTH

Retrieved on: 
Wednesday, June 14, 2023
United States Senate Commerce Subcommittee on Communications, Media, and Broadband, Mother, National Academies of Sciences, Engineering, and Medicine, Native, Policy, PREEMIE Reauthorization Act, Woman, CDC, Congress, Death, National academy, Korea Disease Control and Prevention Agency, Preterm birth, Disease, Infant, Mortality, White, United States House Energy Subcommittee on Health, News, Medicine, Legislation, Dietary supplement, Birth control, Engineering, Health, Christopher Scott Cherot

ARLINGTON, Va., June 14, 2023 /PRNewswire/ -- In testimony before Congress today, March of Dimes Senior Vice President and Chief Medical and Health Officer Dr. Elizabeth Cherot sounded the alarm on the nation's maternal and infant health crisis, saying that supporting women before, during and between pregnancies is integral to improving health outcomes for them and their babies. Cherot called for lawmakers to take swift action to pass critical legislation that can help address this public health crisis.

Key Points: 
  • Cherot called for lawmakers to take swift action to pass critical legislation that can help address this public health crisis.
  • The report shows that 1,205 deaths were reported in 2021, reflecting an increase of nearly 89% in the maternal mortality rate since 2018.
  • Alongside this news, Cherot noted that "the number of women who experience pregnancy-related complications, or severe maternal morbidity, is increasing at a troubling rate."
  • What's more, Cherot said persistent disparities exist across key maternal and infant health indicators.

Power to the Patients to Host Everclear for Special Performance at Congressional Baseball Game Pre-Party

Retrieved on: 
Wednesday, June 14, 2023
Bullpen car, Insurance, White House, Interview, Ibuprofen, Friends, Congressional Baseball Game, Energy, Multimedia, Patients Act 2009, Power, Diagnosis, Patient, Alexakis, United States House Energy Subcommittee on Health, Interstate Commerce Committee, Commerce, Everclear

WASHINGTON, June 13, 2023 /PRNewswire/ -- On Wednesday, June 14, Power to the Patients will host a pre-game party before the Congressional Baseball Game at The Bullpen in Washington, D.C., from 4:00 PM to 7:00 PM EST with a special performance by the band Everclear.

Key Points: 
  • WASHINGTON, June 13, 2023 /PRNewswire/ -- On Wednesday, June 14, Power to the Patients will host a pre-game party before the Congressional Baseball Game at The Bullpen in Washington, D.C., from 4:00 PM to 7:00 PM EST with a special performance by the band Everclear.
  • Art Alexakis, Everclear singer-songwriter and guitarist, was diagnosed with relapsing-remitting multiple sclerosis in 2016, a diagnosis he says blindsided him.
  • "Luckily for me because of the success Everclear has had, I have pretty good insurance through SAG-AFTRA, through my union.
  • Power to the Patients' Congressional Baseball Game Pre-Party Concert is a part of the organization's ongoing grassroots movement to create a more equitable healthcare system through enforcement of healthcare price transparency rules.

NASP Applauds House Committee Action to Support Patient Access to Pharmacies

Retrieved on: 
Thursday, May 25, 2023
Data management, Medicaid, Pharmacy, DIR, Medicare Part D, Pharmacist, Committee, NASP, Medicare, PBM, Specialty pharmacy, Representative, Patient, Nursing, National Association, United States House Energy Subcommittee on Health, Interstate Commerce Committee, Commerce, Legislation, Pharmacy technician, Hospital

Washington, DC, May 25, 2023 (GLOBE NEWSWIRE) -- This week, the House Energy and Commerce Committee passed legislation that supports patients living with life altering and life-threatening medical conditions and the specialty pharmacies that serve them.

Key Points: 
  • Washington, DC, May 25, 2023 (GLOBE NEWSWIRE) -- This week, the House Energy and Commerce Committee passed legislation that supports patients living with life altering and life-threatening medical conditions and the specialty pharmacies that serve them.
  • 3561, which seeks to address anticompetitive practices by certain PBMs as well as to improve transparency across the drug channel.
  • “The real truth here is that practices like spread pricing, pharmacy DIR claw backs and hidden fees on pharmacies are tactics intended to reduce pharmacy network participation and eliminate patient access and choice.
  • With more than 170 corporate members and 3,000 individual members, NASP is unifying the voices of specialty pharmacy.

Dr. Andrea Olariu, CEO - Curae Pharma360 Inc. Statement on U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations

Retrieved on: 
Thursday, May 18, 2023
Drug, American Society of Health-System Pharmacists, Cancer, Energy, Root cause analysis, Patient, Hearing, Change, FDA, United States House Energy Subcommittee on Health, Society, Interstate Commerce Committee, Cura del Popolo, Pharmaceutical industry, Nursing

SAN FRANCISCO, May 18, 2023 /PRNewswire/ -- On May 11, the House Energy and Commerce Committee held a timely and important hearing to identify and raise visibility for the root causes of drug shortages and the obstacles to maintaining a stable supply of critical drugs in the U.S., revealing that more than 200 medications and solutions are currently on the American Society of Health-System Pharmacists' drug shortage list, and 21 of the 36 drugs on the FDA's list of critical medications are currently in shortage.

Key Points: 
  • In fact, our very inception is a response to supply chain and manufacturing challenges that inhibit equitable access to essential care in America.
  • In oncology alone, 15 drugs are currently on the FDA shortage list, dramatically impacting the lives of cancer patients in America.
  • "As we build and implement solutions, we must support the important work of Angels for Change collaborators, like Curae.
  • We applaud the Energy and Commerce Committee for including Ms. Bray's testimony on her family's experience facing three separate oncology drug supply shortages, bringing to light how devastating these shortages are.

As Amoxicillin Shortage Continues, USAntibiotics Urges Lawmakers to Consider Policies and Partnerships That Support U.S. Drug Manufacturers

Retrieved on: 
Thursday, May 11, 2023
Congressional News, Views, Public Policy, Government, Healthcare Reform, White House, Federal Government, State, Local, General Health, Pharmaceutical, Health, Other Policy Issues, Amoxicillin, Public, Medicine, Amoxicillin/clavulanic acid, Congress, Hearing, United States House Energy Subcommittee on Health, Pharmaceutical industry

We have witnessed time and again that the root cause of pharmaceutical drug shortages is the lack of domestic manufacturing in the United States,” said Patrick Cashman, president of USAntibiotics.

Key Points: 
  • We have witnessed time and again that the root cause of pharmaceutical drug shortages is the lack of domestic manufacturing in the United States,” said Patrick Cashman, president of USAntibiotics.
  • “As the only remaining American manufacturer of Amoxicillin finished doses, we urge Congress to focus on long-term solutions to protect Americans’ national and public health security.”
    “We believe American medicine should be made in America.
  • It is a public health risk and a national crisis that so much of our medicine and pharmaceutical manufacturing for the United States has been offshored to foreign countries, like China, leaving us vulnerable to their whims and resulting in a lack of transparency and weakened supply chain.
  • For America to build and maintain a sustainable generic drug industry, lawmakers must support policies that prioritize U.S. manufacturers, and ensure public-private partnerships with relevant agencies to give preference to domestically produced drugs,” added Cashman.

AVMA President to testify before Congress

Retrieved on: 
Wednesday, March 29, 2023
United States Senate Commerce Subcommittee on Communications, Media, and Broadband, AVMA, Veterinarian, Public, Animal, Collection, Patient, Veterinary medicine, FDA, United States House Energy Subcommittee on Health, Food, Legislation, Pharmaceutical industry, Medical device, Health

WASHINGTON, March 29, 2023 /PRNewswire/ -- Dr. Lori Teller, AVMA President, will testify before the House Energy and Commerce Subcommittee on Health on March 30, 2023, at 9:00 AM ET to discuss the importance of reauthorizing the Animal Drug User Fee Act (ADUFA) and the Animal Generic Drug User Fee Act (AGDUFA). The legislation is up for reauthorization every five years and is critical to ensuring a predictable pathway to market for new and innovative animal drugs and generic animal drugs.

Key Points: 
  • WASHINGTON, March 29, 2023 /PRNewswire/ -- Dr. Lori Teller, AVMA President, will testify before the House Energy and Commerce Subcommittee on Health on March 30, 2023, at 9:00 AM ET to discuss the importance of reauthorizing the Animal Drug User Fee Act (ADUFA) and the Animal Generic Drug User Fee Act (AGDUFA).
  • The AVMA supports the collection and effective utilization of user fees to enhance the U.S. Food and Drug Administration Center for Veterinary Medicine's (FDA CVM) review and approval of pioneer and generic animal drugs.
  • Throughout 2022, the AVMA provided verbal and written comments to the FDA CVM regarding the needs of veterinarians in the reauthorization of these programs.
  • The AVMA supports:
    The FDA CVM adopting processes used by other similar regulatory agencies that could streamline and shorten the time needed to approve products for U.S. markets.

Done., Patient Advocates, and Stakeholders Call For Vital Patient Access To Telehealth

Retrieved on: 
Thursday, October 20, 2022
Online, Suicide, Congress, Time, United States Senate Commerce Subcommittee on Communications, Media, and Broadband, Kaiser Permanente, Technology, White House, Partner, Public health, Gaps, Attention, Venable LLP, Policy, COVID, Drug, DEA, ADHD, Patient, United States House Energy Subcommittee on Health, Consumer protection, Depression, White, Telehealth, Attention deficit hyperactivity disorder predominantly inattentive, PHE, Public health emergency, Awareness, Venable, Rocketplane Global Inc., UCLA, Drug Enforcement Administration, Interstate Commerce Committee, World Mental Health Day, Substance-related disorder, Founder, Adult, Safety, Letter, Management, Anxiety, Travel, Communication, Attention deficit, Prescription, Physical, Pharmaceutical industry, Medicine, Done, Health

WASHINGTON, Oct. 20, 2022 /PRNewswire-PRWeb/ -- The founder of Done. Global Inc., a leading telehealth provider of services for people with attention-deficit/hyperactivity disorder (ADHD), joined renowned medical experts, patients, and a former member of Congress during a policy briefing to advocate for regulatory relief that would permanently allow some clinicians to prescribe medications online without the need to meet in person.

Key Points: 
  • Generally, to prescribe controlled substances via telehealth a provider has to first have had an in-person encounter with the patient.
  • However, the in-person requirement has been suspended during the declared federal Public Health Emergency but could be changed at any time.
  • and board-certified psychiatrist from UCLA who previously worked at institutions like Kaiser Permanente; and the Founder of Done.
  • "Telehealth has been groundbreaking for many patients who do not have easy access to doctors, never mind specialty providers," said Dr. Martinez.

Center for Contemporary Sciences (CCS) Applauds the Senate for Passing the FDA Modernization Act 2.0, Recognizing the Great Bipartisan Efforts of Senators Rand Paul and Cory Booker.

Retrieved on: 
Thursday, September 29, 2022
Federal Food, Drug, and Cosmetic Act, FFDCA, Human, FDA, Food, Center, Legislation, Emulate, Food and Drug Administration Modernization Act of 1997, News, Jane Goodall, HELP, United States Senate Committee on Health, Education, Labor and Pensions, Senate, CCS, Biology, United States House Energy Subcommittee on Health, House, Drug development, Negotiation, Jane Goodall Institute, Commerce, United States Senate, Conference, Actin, Multimedia, Education, Labour, View, Pharmaceutical industry, Pension, Health

In swift reaction, Senators Booker and Paul reintroduced the FDA Modernization Act 2.0, S.5002 separately for consideration by the Senate today.

Key Points: 
  • In swift reaction, Senators Booker and Paul reintroduced the FDA Modernization Act 2.0, S.5002 separately for consideration by the Senate today.
  • In doing so, the FDA Modernization Act introduces much-needed improvement to the process of drug development.
  • A growing number of stakeholders have voiced their support for the FDA Modernization Act.
  • Center for Contemporary Sciences (CCS) is pioneering a paradigm shift towards innovative, evidence-based research methods that are based on human biology.

CAARE Joins Inaugural 'World Day of Animal Free Research' on May 27; Notes U.S. Legislation to Remove FDA's Animal Testing Mandate

Retrieved on: 
Thursday, May 26, 2022
People, Food and Drug Administration Modernization Act of 1997, Animal Free Research UK, Medicine, NEW, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Ethics, Liver, Fatality, Emulate, National Center for Health Research, Patient, Biology, Vaccine, Liver injury, Hiloni, Hepatotoxicity, Interstate Commerce Committee, Legislation, FDA, Method, Alternatives, World Day for Laboratory Animals, Public policy, Latin American Center for Human Economy, Lord Dowding Fund for Humane Research, Center, United States House Energy Subcommittee on Health, Toxicity, Human, United States House Committee on Energy and Commerce, CAARE, Genomics, USC Michelson Center for Convergent Bioscience, National, Animal, Pharmaceutical industry, Dietary supplement, Online gambling, Medical device, Experiment, Research, Animal

NEW YORK, May 26, 2022  /PRNewswire-PRWeb/ -- Citizens for Alternatives to Animals in Research and Experimentation (CAARE) – a non-governmental nonprofit that is promoting federal legislation to phase out the use of animals in testing – has announced its participation in the inaugural World Day of Animal Free Research on May 27, 2022, introduced in the UK by the organization, Animal Free Research.

Key Points: 
  • On this inaugural day, Citizens for Alternatives to Animal Research and Experimentation is highlighting pending federal legislation with the potential to pass this year that will remove the animal testing mandate from the FDA.
  • An estimated 90 to 95 percent of drugs and vaccines found safe in animal tests fail during human clinical trials.
  • "World Day for Animal Free Research recognizes that it's time we put more resources into modernizing medicine by shifting away from animals.
  • Citizens for Alternatives to Animal Research and Experimentation (CAARE), is a 501(c)(3) non-profit organization, established to highlight and promote research without animals.